PedAM
Pediatric Disease Annotations & Medicines
| Disease | mental depression |
| Phenotype | |multiple sclerosis |
| Sentences | 58 |
| PubMedID- 23915778 | Perfectionism and physical disability predict depression in multiple sclerosis. |
| PubMedID- 21328292 | Pharmacologic treatment of depression in multiple sclerosis. |
| PubMedID- 26401158 | The results obtained from multiple logistic regression analysis showed that the disease course (or for relapsing–remitting ms = 2.36, % 95 ci = 1.14–5.53, p = 0.46), the expanded disability status scale (or for score of 5–8 = 4.88, % 95 ci = 2.51–11.06, p < 0.001) and employment status (or for housewife = 4.75, % 95 ci = 1.55–14.58, p = 0.006) were significant contributing factors to depression in patients with multiple sclerosis. |
| PubMedID- 22527232 | Quality of life and depression in multiple sclerosis patients: longitudinal results of the betaplus study. |
| PubMedID- 26254948 | Objective: to evaluate the efficacy of a telephone-delivered self-management intervention for fatigue, pain, and depression in adults with multiple sclerosis (ms). |
| PubMedID- 26359900 | An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. |
| PubMedID- 24902042 | Background: in multiple sclerosis (ms) patients, symptoms of anxiety, depression, pain, and cognitive impairment are highly prevalent and contribute to lower wellbeing. |
| PubMedID- 22168507 | Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. |
| PubMedID- 23244804 | Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. |
| PubMedID- 20204955 | We assessed the applicability of ccbt for the treatment of depression in people with multiple sclerosis (ms). |
| PubMedID- 24501169 | Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. |
| PubMedID- 19660239 | Neuropsychiatric manifestations in multiple sclerosis: correlation of fatigue and depression with disease progression. |
| PubMedID- 26008945 | Selective serotonin-reuptake inhibitors (ssris), commonly administered for depression and anxiety in patients with multiple sclerosis, are associated with qt interval prolongation. |
| PubMedID- 24406031 | We systematically reviewed published controlled trials on the effectiveness of cognitive behavioural therapy (cbt) for the treatment of depression in people with multiple sclerosis. |
| PubMedID- 25061435 | Background: valid assessments are needed in order to identify anxiety and depression in people with multiple sclerosis (ms). |
| PubMedID- 22860028 | A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the uk ms register. |
| PubMedID- 21432735 | depression in multiple sclerosis: reactive or endogenous. |
| PubMedID- 23783007 | Objectives: duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for its therapeutic efficacy, safety, and tolerability in the treatment of depression in patients with multiple sclerosis (ms). |
| PubMedID- 23713732 | The co-occurrence of pain and depression in adults with multiple sclerosis. |
| PubMedID- 25580882 | Disability identity predicts lower anxiety and depression in multiple sclerosis. |
| PubMedID- 24559790 | Objective: the prevalence of depression in multiple sclerosis (ms) is known to be elevated, but nearly all available studies have estimated period prevalence. |
| PubMedID- 20809354 | The purpose of the study was to evaluate the prevalence of insomnia in multiple sclerosis patients with comorbid depression, associations between psychological symptoms, multiple sclerosis symptoms and insomnia, and to test effects of a 16-week protocol-based psychotherapy intervention for depression on insomnia symptoms. |
| PubMedID- 24852924 | depression in multiple sclerosis: a long-term longitudinal study. |
| PubMedID- 21585189 | depression in multiple sclerosis patients. |
| PubMedID- 19941048 | This study is a secondary analysis from a randomized clinical trial examining telephone-administered psychotherapy treatments for depression among patients with multiple sclerosis (please see mohr et al. |
| PubMedID- 24926444 | [26] forty sessions of ai chi aquatic exercise (ae) program improves pain, spasms, disability, fatigue, depression, and autonomy in patient with multiple sclerosis. |
| PubMedID- 25933976 | Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. |
| PubMedID- 26445703 | Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. |
| PubMedID- 23812284 | Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. |
| PubMedID- 26351621 | A brief description of the pathophysiology and effects of depression in patients with multiple sclerosis is also provided. |
| PubMedID- 25603363 | Conclusion our study suggests that coq10 supplementation (500 mg/day) can improve fatigue and depression in patients with multiple sclerosis. |
| PubMedID- 23460394 | Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study. |
| PubMedID- 23379265 | Telephone-based physical activity counseling for major depression in people with multiple sclerosis. |
| PubMedID- 23438712 | Objective: the present study examined the relationship between volitional modes of coping (self-regulation, volitional inhibition, and self-control) and depression in individuals with multiple sclerosis. |
| PubMedID- 23095427 | Evaluation of the 9-item patient health questionnaire (phq-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. |
| PubMedID- 23754606 | Commentary on: predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study. |
| PubMedID- 25362584 | Effect of neurofeedback training on depression and fatigue in patients with multiple sclerosis. |
| PubMedID- 25628596 | Stroop: msqol, multiple sclerosis quality of life; madrs, montgomery–asberg depression rating scale; mfis, modified fatigue impact scale002e. |
| PubMedID- 26242758 | Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care hospital in oman. |
| PubMedID- 20804269 | Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis. |
| PubMedID- 20007425 | depression is common in patients with multiple sclerosis, but to date no studies have explored diffusion tensor imaging indices associated with mood change. |
| PubMedID- 21995045 | In our experiments, we demonstrate the robustness of our method by applying it to map hippocampal atrophy of multiple sclerosis patients with depression on a data set of 109 subjects. |
| PubMedID- 24453767 | Attributional style and depression in multiple sclerosis: the learned helplessness model. |
| PubMedID- 24653957 | Objective: the aim of this study was to investigate the course of alexithymia and its relation with anxiety and depression in patients with multiple sclerosis (ms), over a period of 5 years. |
| PubMedID- 19822449 | Fatigue and depression in children with multiple sclerosis and monophasic variants. |
| PubMedID- 26223270 | depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure. |
| PubMedID- 26155372 | Sexual dysfunction and depression in individuals with multiple sclerosis: is there a link. |
| PubMedID- 21948887 | Pathogenic mechanisms of depression in multiple sclerosis. |
| PubMedID- 20663242 | Both social support and stress predict depression in multiple sclerosis (ms) patients. |
| PubMedID- 24574558 | Severity of depression in multiple sclerosis also was reported to have association with multiple sclerosis. |
Page: 1 2